Innovative Therapeutics Reglagene specializes in designing brain-penetrant medicines aimed at treating neurological disorders, positioning it as a leader in breakthrough brain disease therapeutics with high potential for partnerships in pharma and biotech sectors.

Recognition & Visibility The company's recent awards and recognitions, including the Outstanding Client Award at InBIA and being named a company to watch, enhance its credibility and attractiveness to investors and collaborators seeking innovative biotech ventures.

Strategic Expansion Expansion into Houston’s Texas Medical Center indicates a growing footprint within major life science hubs, offering access to a rich ecosystem of researchers and potential corporate partnerships.

Funding & Revenue With annual revenue between 1 and 10 million dollars and secured funding of 767K, Reglagene shows healthy early-stage growth potential, making it appealing for strategic investments or licensing collaborations.

Scientific & Tech Focus Utilizing advanced tech stacks and operating in a niche biotech research industry, Reglagene opens opportunities for technology licensing, joint research initiatives, and product development collaborations.